Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 6:30 AM ET

Life Sciences Tools and Services

Company Overview of Pharmaceutical Research Associates, Inc.

Company Overview

Pharmaceutical Research Associates, Inc. provides clinical development services. Its services include drug development and regulatory strategy plans, phase I clinical trials, phase II through IV multi-center clinical trials, development and analysis of integrated global clinical databases, preparation and submission of regulatory filings in North America and Europe, and drug safety programs. The company was founded in 1981 and is based in Reston, Virginia. Pharmaceutical Research Associates, Inc. operates as a subsidiary of PRA International, Inc.

12120 Sunset Hills Road

Suite 600

Reston, VA 20190

United States

Founded in 1981

Phone:

703-464-6300

Fax:

703-464-6301

Key Executives for Pharmaceutical Research Associates, Inc.

Secretary
Age: 95
Compensation as of Fiscal Year 2015.

Pharmaceutical Research Associates, Inc. Key Developments

Cymabay Therapeutics, Inc. and Pharmaceutical Research Associates, Inc., Enters into a Master Services Agreement

On September 2, 2015, CymaBay Therapeutics, Inc. and Pharmaceutical Research Associates, Inc., entered into a Master Services Agreement to provide contract clinical research and development services for CymaBay. The Agreement provides that CymaBay may engage PRA from time to time to provide services in accordance with work orders mutually agreed and budgeted between the parties. CymaBay contemplates that the Agreement will be utilized from time to time for clinical research and development of its product candidates and the initial work order includes services with respect to CymaBay’s clinical candidate, MBX-8025 which total is anticipated to be approximately $6.2 million. The Agreement provides customary terms and conditions, including those for performance of services by PRA in compliance with work orders, industry standards, FDA and ICH requirements and all applicable laws. CymaBay remains responsible for all regulatory responsibilities unless specifically transferred to PRA, as well as the determination of any work orders, subject to mutual agreement on the specific terms of any such work orders. The Agreement has a term of five years, provided that, CymaBay may terminate the Agreement or any individual work order or the Agreement on thirty days written notice. In addition, either party may terminate the Agreement or any applicable work order upon thirty days written notice for a material breach by the other party or immediately in the event of any bankruptcy, insolvency, liquidation or assignment for the benefit of creditors.

Similar Private Companies By Industry

Company Name Region
Thaddeus Medical Systems, Inc. United States
Cannabics Inc. United States
Clinical Supplies Management, Inc. United States
Seventh Wave Laboratories LLC United States
Mystic Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Pharmaceutical Research Associates, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.